Olodaterol

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Indacaterol. Indications Asthma and COPD

EU and US DMF available

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Loratadine. Indication: Allergy

JP DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Montelukast sodium. Indication: Asthma, allergic and seasonal rhinitis

EU and JP DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Nitrendipine. Indication: Hypertension

CEP an DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Olanzapine. Indications: Schizophrenia, psychosis

EU and US DMF

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Olanzapine pamoate. Indications: Schizophrenia, psychosis

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Ondansetron base. Indication: Emesis

EU-US DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Ondansetron hydrochloride. Indication: Emesis

CEP and US DMF

Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Prasugrel base. Indication: Prophylaxis and therapy of thrombosis

EU DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Quetiapine hemifumarate. Indication: Schizophrenia, psychosis

JP and KR DMF

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Revefenacin for COPD treatment

Inke (API manufacturer) part of  Neuraxpharm, provides wide range of APIs which includes Risperidone (sterile). Indication: Schizophrenia, psychosis

CEP and US-KR DMF

Complete overview of Inke’s API product portfolio and development pipeline, covering Inhalation, CNS, Ophthalmic HPAPIs and Specialty APIs. The document includes product indications, micronisation availability, regulatory status (CEPs and DMFs), and development stage information for pipeline products.